[Mechanism of miRNA-3679 Inhibiting Downstream ZADH2-Target Genes to Promote Hepatocellular Carcinoma Cell Proliferation].

Sichuan Da Xue Xue Bao Yi Xue Ban

Department of Liver Surgery,West China Hospital, Sichuan University, Chengdu 610041, China.

Published: September 2022

AI Article Synopsis

  • The study aimed to explore the connection between miRNA-3679 and hepatocellular carcinoma (HCC) cell lines, as well as identify the downstream target genes associated with miRNA-3679.
  • Researchers employed methods like PCR, qPCR, Western blot, EdU staining, and flow cytometry to assess miRNA-3679 expression, its target gene ZADH2, and the impacts on cell proliferation and apoptosis.
  • Results indicated that miRNA-3679 was upregulated in HCC cell lines, and inhibiting it led to increased expression of ZADH2, reduced cell proliferation, and altered clone formation abilities in cancer cells.

Article Abstract

Objective: To examine the relationship between miRNA-3679 and hepatocellular carcinoma (HCC) cell lines, and to verify the downstream target genes of miRNA-3679.

Methods: PCR was used to determine the expression of miRNA-3679 in liver cancer cell lines, and databases, including ENCORI, miRDB and TargetScan, were used to predict the downstream target genes of miRNA-3679. qPCR of the normal control group (or NC group), miR-3679 inhibitor group and transfection negative control group (or inhibitor NC group) was done to determine the transfection efficiency of the target gene, thereby identifying zinc-binding alcohol dehydrogenase domain containing 2 () as the target gene. Western blot was used to determine the ZADH2 protein expression after miRNA-3679 inhibitor transfection. 5-Ethynyl-2'-deoxyuridine (EdU) staining was done to determine the effect of transfection of miRNA-3679 inhibitor and simultaneous transfection of miRNA-3679 and ZADH2 inhibitors on cell proliferation. Clone formation assay was done to determine the ability of cell clone formation. Flow cytometry was done to examine cell apoptosis.

Results: The expression level of miRNA-3679 in HCC cell lines was higher than that in normal human liver cell lines (<0.05). Through screening conducted with the databases, six genes, including 1, 31, 463, 23, 5, and 2, were found to be down-regulated in HCC. qPCR showed that 2 expression increased significantly after transfection with miRNA-3679 inhibitor (<0.01) and luciferase activity increased after transfection with miR-3679 inhibitor (<0.01). Western blot results showed that ZADH2 protein expression of the miR-3679 inhibitor group was higher than that of the NC group (<0.01). EdU analysis showed that the number of positive cells in the miRNA-3679 inhibitor group was lower than that in the NC group and the Inhibitor NC group (<0.05). The clone count of the miR-3679 inhibitor+si-2 group was significantly higher than that of the miR-3679 inhibitor group (<0.01). Flow cytometry showed that the number of apoptotic cells of the miR-3679 inhibitor+si-2 group was significantly lower than that of the miR-3679 inhibitor group (<0.01).

Conclusion: miRNA-3679 is significantly highly expressed in HCC cells and miRNA-3679 can directly interact with 2 gene and affect its expression. Moreover, miRNA-3679 promotes the proliferation of HCC cells and inhibits their apoptosis by suppressing ZADH2.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408807PMC
http://dx.doi.org/10.12182/20220960505DOI Listing

Publication Analysis

Top Keywords

cell lines
16
hepatocellular carcinoma
8
cell
8
hcc cell
8
downstream target
8
target genes
8
expression mirna-3679
8
control group
8
inhibitor group
8
determine transfection
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!